Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Pseudomonas

ABSTRACT: Whole genome sequencing of carbapenem non-susceptible Pseudomonas in a Singapore hospital

PROVIDER: PRJNA656645 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12669000_1.fastq.gz	Fastqsanger.gz
	SRR12669000_2.fastq.gz	Fastqsanger.gz
	SRR12669001_1.fastq.gz	Fastqsanger.gz
	SRR12669001_2.fastq.gz	Fastqsanger.gz
	SRR12669002_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 598

Similar Datasets

Enterobacteriaceae

Project description:Whole genome sequencing of carbapenem non-susceptible Enterobacterales in a Singapore hospital

| PRJNA577535 | ENA

Acinetobacter

Project description:Whole genome sequencing of carbapenem non-susceptible Acinetobacter in a Singapore hospital

| PRJNA664284 | ENA

Project description:Pseudomonas aeruginosa carbapenem resistant and susceptible isolates, Singapore

| PRJNA1197548 | ENA

Pseudomonas aeruginosa Jakarta

Project description:Clinical samples from a genomic characterization of Carbapenem-non-susceptible Pseudomonas aeruginosa strains from two ICUs from the referral national hospital in Jakarta, Indonesia.

| PRJEB30625 | ENA

Environmental Pseudomonas aeruginosa Jakarta

Project description:Environmental samples from a genomic characterization of Carbapenem-non-susceptible Pseudomonas aeruginosa strains from two ICUs from the referral national hospital in Jakarta, Indonesia.

| PRJEB32907 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Pseudomonas aeruginosa

Project description:Carbapenem resistant Pseudomonas aeruginosa from two time periods in a Houston Hospital

| PRJNA896240 | ENA

Determination of carbon metabolism response regulators regulons in several Pseudomonas species by DAP-seq

Project description:We identified binding sites genome-wide for carbon metabolism transcriptional response regulators in Pseudomonas stutzeri RCH2, Pseudomonas putida KT2240, Pseudomonas fluorescens FW300-N2E2 and FW300-N2C3 by DNA-affinity-purified (DAP) sequencing.

2020-10-01 | GSE157075 | GEO

Pseudomonas aeruginosa strain:K19PSE24 | isolate:Pseudomonas aeruginosa

Project description:Carbapenem-resistant Pseudomonas aeruginosa Genome sequencing K19PSE24

| PRJNA632718 | ENA

Enterobacteriaceae

Project description:Carbapenem-resistant Enterobacteriaceae within a single hospital network in Singapore Genome sequencing and assembly

| PRJNA674942 | ENA